Equifax [EFX] vs Verisk Analytics [VRSK] Detailed Stock Comparison
Equifax
NYSE
Loading...
Verisk Analytics
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Equifax wins in 6 metrics, Verisk Analytics wins in 14 metrics, with 0 ties. Verisk Analytics appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Equifax | Verisk Analytics | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 47.97 | 42.02 | Verisk Analytics |
| Price-to-Book Ratio | 5.97 | 121.47 | Equifax |
| Debt-to-Equity Ratio | 93.55 | 1,096.55 | Equifax |
| PEG Ratio | 2.88 | -2.59 | Verisk Analytics |
| EV/EBITDA | 19.52 | 28.10 | Equifax |
| Profit Margin (TTM) | 10.95% | 30.68% | Verisk Analytics |
| Operating Margin (TTM) | 20.22% | 46.08% | Verisk Analytics |
| EBITDA Margin (TTM) | 20.22% | 46.08% | Verisk Analytics |
| Return on Equity | 12.76% | 243.11% | Verisk Analytics |
| Return on Assets (TTM) | 5.80% | 17.29% | Verisk Analytics |
| Free Cash Flow (TTM) | $813.00M | $920.10M | Verisk Analytics |
| Dividend Yield | 0.46% | 0.76% | Verisk Analytics |
| 1-Year Return | -15.61% | 1.09% | Verisk Analytics |
| Price-to-Sales Ratio (TTM) | 5.19 | 12.68 | Equifax |
| Enterprise Value | $35.51B | $40.66B | Verisk Analytics |
| EV/Revenue Ratio | 6.08 | 13.62 | Equifax |
| Gross Profit Margin (TTM) | 56.76% | 70.30% | Verisk Analytics |
| Revenue per Share (TTM) | $47 | $21 | Equifax |
| Earnings per Share (Diluted) | $5.13 | $6.45 | Verisk Analytics |
| Beta (Stock Volatility) | 1.64 | 0.83 | Verisk Analytics |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Equifax vs Verisk Analytics Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Equifax | 3.89% | 2.94% | 6.96% | -3.19% | 6.31% | 1.54% |
| Verisk Analytics | -0.30% | 1.21% | -9.07% | -13.76% | -8.73% | -0.84% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Equifax | -15.61% | 29.36% | 51.45% | 159.01% | 753.13% | 663.70% |
| Verisk Analytics | 1.09% | 42.75% | 44.68% | 266.59% | 870.85% | 926.74% |
Performance & Financial Health Analysis: Equifax vs Verisk Analytics
| Metric | EFX | VRSK |
|---|---|---|
| Market Information | ||
| Market Cap | $30.32B | $37.86B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 995,241 | 1,098,410 |
| 90 Day Avg. Volume | 1,118,924 | 1,109,680 |
| Last Close | $255.00 | $271.09 |
| 52 Week Range | $199.98 - $309.63 | $259.01 - $322.92 |
| % from 52W High | -17.64% | -16.05% |
| All-Time High | $309.63 (Sep 16, 2024) | $322.92 (Jun 05, 2025) |
| % from All-Time High | -17.64% | -16.05% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.07% | 0.08% |
| Quarterly Earnings Growth | 0.17% | -0.18% |
| Financial Health | ||
| Profit Margin (TTM) | 0.11% | 0.31% |
| Operating Margin (TTM) | 0.20% | 0.46% |
| Return on Equity (TTM) | 0.13% | 2.43% |
| Debt to Equity (MRQ) | 93.55 | 1,096.55 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $41.22 | $2.23 |
| Cash per Share (MRQ) | $1.53 | $4.51 |
| Operating Cash Flow (TTM) | $1.39B | $1.24B |
| Levered Free Cash Flow (TTM) | $864.12M | $846.06M |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.46% | 0.76% |
| Last 12-Month Dividend | $1.17 | $2.13 |
Valuation & Enterprise Metrics Analysis: Equifax vs Verisk Analytics
| Metric | EFX | VRSK |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 47.97 | 42.02 |
| Forward P/E | 26.15 | 37.18 |
| PEG Ratio | 2.88 | -2.59 |
| Price to Sales (TTM) | 5.19 | 12.68 |
| Price to Book (MRQ) | 5.97 | 121.47 |
| Market Capitalization | ||
| Market Capitalization | $30.32B | $37.86B |
| Enterprise Value | $35.51B | $40.66B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 6.08 | 13.62 |
| Enterprise to EBITDA | 19.52 | 28.10 |
| Risk & Other Metrics | ||
| Beta | 1.64 | 0.83 |
| Book Value per Share (MRQ) | $41.22 | $2.23 |
Financial Statements Comparison: Equifax vs Verisk Analytics
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | EFX | VRSK |
|---|---|---|
| Revenue/Sales | $1.44B | $753.00M |
| Cost of Goods Sold | $656.70M | $230.80M |
| Gross Profit | $785.30M | $522.20M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $235.80M | $330.10M |
| EBITDA | $414.70M | $413.30M |
| Pre-Tax Income | $185.40M | $296.40M |
| Income Tax | $51.60M | $64.10M |
| Net Income (Profit) | $133.80M | $232.30M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | EFX | VRSK |
|---|---|---|
| Cash & Equivalents | $195.20M | $1.11B |
| Total Current Assets | $1.48B | $1.77B |
| Total Current Liabilities | $1.73B | $1.40B |
| Long-Term Debt | $4.32B | $3.39B |
| Total Shareholders Equity | $5.11B | $123.80M |
| Retained Earnings | $6.10B | $7.32B |
| Property, Plant & Equipment | $285.10M | $747.90M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | EFX | VRSK |
|---|---|---|
| Operating Cash Flow | $223.90M | $472.80M |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | $116.70M | $391.00M |
| Debt Repayment | $-48.10M | N/A |
| Common Stock Repurchase | N/A | $-200.10M |
Short Interest & Institutional Ownership Analysis
| Metric | EFX | VRSK |
|---|---|---|
| Shares Short | 2.82M | 2.50M |
| Short Ratio | 2.61 | 2.42 |
| Short % of Float | 0.03% | 0.02% |
| Average Daily Volume (10 Day) | 995,241 | 1,098,410 |
| Average Daily Volume (90 Day) | 1,118,924 | 1,109,680 |
| Shares Outstanding | 123.95M | 140.41M |
| Float Shares | 123.19M | 139.25M |
| % Held by Insiders | 0.01% | 0.00% |
| % Held by Institutions | 0.98% | 0.96% |
Dividend Analysis & Yield Comparison: Equifax vs Verisk Analytics
| Metric | EFX | VRSK |
|---|---|---|
| Last 12-Month Dividend | $1.17 | $2.13 |
| Last 12-Month Dividend Yield | 0.46% | 0.76% |
| 3-Year Avg Annual Dividend | $1.30 | $1.63 |
| 3-Year Avg Dividend Yield | 0.17% | 0.16% |
| 3-Year Total Dividends | $3.90 | $4.89 |
| Ex-Dividend Date | Feb 21, 2025 | Sep 15, 2025 |